Detail akcie TERUMO online

Business Summary: Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, Terumo Corp revenues increased 12% to Y1.036T. Net income applicable to common stockholders increased 10% to Y116.98B. Revenues reflect Cardiovascular area business segment increase of 12% to Y624.36B, Hospital business segment increase of 7% to Y211.23B, Eliminations and Corporate segment increase of 20% to Y298M, Americas segment increase of 21% to Y395.65B, Europe segment increase of 14% to Y218.29B.